Bispecific antibodies (BsAbs) are an emerging class of engineered biologics designed to simultaneously bind two distinct antigens or epitopes. By enabling dual-target engagement, bispecific antibodies offer unique mechanisms of action that extend beyond conventional monoclonal antibodies, particularly in oncology and immuno-oncology. In recent years, advances in protein engineering, manufacturing, and clinical development have accelerated the…